ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666870 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666870; 2) Community: the network communities that were significantly associated with the response to NSC 666870; 3) Molecule: the relationships between components within communities and NSC 666870; 4) MDR: the compounds that were significantly associated with the NSC 666870.

NSC Compound Enrichment Correlation
NSC 681635 Camptothecin Derivative 0.00356954838698626 0.4356025
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.00356954838698626 0.084428616
NSC 639174 Camptothecin Derivative 0.00356954838698631 0.45920212
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00356954838698631 0.33885974
NSC 144153 Datiscoside 0.0036112018156453 0.12472413
NSC 606869 Clofarabine 0.0036112018156453 0.2395469
NSC 650744 1,1'-Biphenyl, 4,4'bis(thiomethyl)- 0.0036112018156453 0.28812289
NSC 663791 Null 0.0036112018156453 0.63666661
NSC 691900 Null 0.0036112018156453 0.074501614
NSC 719211 11-(4'-Iodobutylidene)-5,6-dihydro-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-5-oxo-11H-indeno[1,2-c]isoquinoline 0.0036112018156453 0.42822951
Total:29  Current:3    [First] [Prev] [Next] [Last]